Catalyst Wire Dossier Catalyst Wire Dossier

Fosamprenavir

fosamprenavir · Bristol-Myers Squibb
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for Fosamprenavir, covering 2009-02-23 to 2026-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Fosamprenavir for Laryngopharyngeal Upper Airway Tissue Treatment and Enzyme Reduction [Phase 2]

See pricing